Corbus Pharmaceuticals Holdings, Inc. (CRBP) Net income 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$78.5MFY2025 · since FY2016: -$20.0M → -$78.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$78.5M | -95.3% |
| FY2024 | -$40.2M | +9.9% |
| FY2023 | -$44.6M | -5.3% |
| FY2022 | -$42.3M | +7.2% |
| FY2021 | -$45.6M | +59.0% |
| FY2020 | -$111.3M | -55.7% |
| FY2019 | -$71.5M | -28.3% |
| FY2018 | -$55.7M | -71.7% |
| FY2017 | -$32.4M | -62.1% |
| FY2016 | -$20.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBP financial trends
CRBP RevenueCRBP Net marginCRBP Gross profitCRBP Gross marginCRBP Operating incomeCRBP Operating marginCRBP Operating cash flowCRBP Free cash flowCRBP Capital expendituresCRBP Return on equityCRBP Stock buybacksCRBP Dividends paidCRBP Total assetsCRBP Total liabilitiesCRBP Shareholders’ equityCRBP overview →